Marina Udier-Blagovic

Marina Udier-Blagovic is a seasoned executive in the oncology and biopharmaceutical sectors, currently serving as a Board Member at Celyad Oncology since December 2020 and Chief Executive Officer of Nouscom AG, where leadership spans various roles since August 2016, focusing on patient-specific immunotherapy. Previous experience includes roles at Keires AG as Board Director, overseeing business strategy in GMP manufacturing for viral vaccines, and at Novartis, where significant accomplishments involve leading global commercial strategies for diagnostics and established brands. Marina has a robust background in management consulting with McKinsey & Company and holds a PhD in Organic Chemistry from Yale University, complemented by multiple publications in leading scientific journals.